Clive Hyman: Prevention of future deaths report
Skip to related content
Date of report: 22/01/2026
Ref: 2026-0034
Deceased name: Clive Hyman
Coroner name: Sarah Bourke
Coroner Area: Inner North London
Category: Other related deaths
This report is being sent to: Medicine and Healthcare Products Regulatory Agency | Association of the British Pharmaceutical Industry | Medicines UK
| THIS REPORT IS BEING SENT TO: Chair, Medicines and Healthcare Products Regulatory Agency Chief Executive, Association of the British Pharmaceutical Industry Chief Executive, Medicines UK | |
| 1 | I am Sarah Bourke, HM Assistant Coroner for the coroner area of Inner North London. |
| 2 | I make this report under paragraph 7, Schedule 5, of the Coroners and Justice Act 2009 and Regulations 28 and 29 of the Coroners (Investigations) Regulations 2013. |
| 3 | On 21 August 2025, Senior Coroner Hassell commenced an investigation into the death of Clive Mark Hyman aged 64 years. The investigation concluded at the end of the inquest on 13 January 2026. The conclusion of the inquest was that “Mr Hyman presented with severe brain injuries a few days after falling and hitting his head. He died in hospital on 10 August 2025”. I returned a conclusion that death was due to accident. The medical cause of death was: 1a traumatic subdural haemorrhage (operated); 2 atrial fibrillation (treated with apixaban), coronary artery bypass graft. |
| 4 | Mr Hyman was 64 years old, active and in good general health. He was prescribed apixaban following treatment for atrial fibrillation and a coronary artery bypass graft. On 1 August 2025, Mr Hyman tripped on the stairs whilst making a telephone call. He informed his colleague that he had hit his head but was feeling “fine”. He subsequently told his wife about falling on some marble steps. Mr Hyman did not seek medical advice following the fall. Neither he nor his wife was aware that taking apixaban presented a risk in relation to head trauma. Mr Hyman presented normally until 1 pm on 5 August 2025 when he developed a sudden, severe headache. His blood pressure was also extremely high. His wife called the ambulance service and was told that it was a “non- emergency”. Mr Hyman took some paracetamol and went to bed. Around 3.45 pm, his wife heard him choking. She saw that he had vomited and was unresponsive. A further call was made to the ambulance service, paramedics attended and conveyed Mr Hyman to his local emergency department. A CT scan revealed that Mr Hyman had a left-sided subdural haemorrhage. He was given prothrombin and tranexamic acid to help reverse apixaban and given hypertonic saline prior to being transferred to the regional trauma centre. Mr Hyman underwent an emergency left-sided decompressive craniectomy on arrival which was uneventful. He was transferred to the adult critical care unit. A CT scan taken on 6 August showed that Mr Hyman had bleeding within the pons and changes consistent with an ischaemic stroke. Sedation was withdrawn on 8 August, but Mr Hyman continued to have a profoundly decreased level of consciousness. Further imaging on 9 August established that he had had an extensive stroke affecting the entirety of the left hemisphere of the brain. Neurosurgeons advised that the prospects of any meaningful recovery were poor. Mr Hyman died in the early hours of 10 August. |
| 5 | ORONER’S CONCERNS During the course of the inquest the evidence revealed matters giving rise to concern. In my opinion there is a risk that future deaths could occur unless action is taken. In the circumstances it is my statutory duty to report to you. The MATTERS OF CONCERN are as follows. 1) NICE guidelines NG232 on the Assessment and Early Management of Head Injury state at paragraph 1.2.1 “Public health literature and other 2) Having reviewed several patient information leaflets issued with apixaban, it is evident that patients are routinely advised not to take the drug if they are “bleeding excessively”. In addition, they are advised to seek medical advice if they are at “increased risk of bleeding”. None of the patient information leaflets that I reviewed expressly addressed the steps to be taken by a patient if they sustain trauma to the head. 3) Patients who have experienced head trauma may not realise that they have sustained an intracranial bleed. As head injuries can be asymptomatic for some time following trauma, apixaban users may continue taking the medication and avoid seeking medical advice because they feel well. As a result of taking apixaban, bleeding may continue. By the time symptoms of a brain injury emerge (e.g. a sudden, severe headache) the patient may be critically ill and have a reduced potential for recovery. |
| 6 | In my opinion action should be taken to prevent future deaths and I believe you and your organisation have the power to take such action. |
| 7 | You are under a duty to respond to this report within 56 days of the date of this report, namely by 19 March 2026. I, the coroner, may extend the period. Your response must contain details of action taken or proposed to be taken, setting out the timetable for action. Otherwise, you must explain why no action is proposed. |
| 8 | I have sent a copy of my report to the Chief Coroner and to the following Interested Persons: Family of Clive Hyman The Chief Coroner may publish either or both in a complete or redacted or summary form. She may send a copy of this report to any person who she believes may find it useful or of interest. You may make representations to me, the coroner, at the time of your response, about the release or the publication of your response by the Chief Coroner. |
| 9 | HM Assistant Coroner 22 January 2026 |